-
March 5, 2019 Lupin in alliance with Natco receives FDA approval for Imatinib Mesylate Tablets
-
February 28, 2019 Lupin receives FDA approval for Azacitidine for Injection, 100 mg Single-Dose Vial
-
February 26, 2019 Lupin launches generic Minocycline Hydrochloride ER Tablets USP
-
February 25, 2019 Lupin receives FDA approval for Methylprednisolone Tablets USP
-
February 15, 2019 Lupin launches Clobazam Oral Suspension, 2.5mg/mL
-
February 12, 2019 Lupin receives FDA approval for Fluoxetine Tablets USP
-
February 8, 2019 U.S. FDA completes inspection of Lupin’s Goa facility
-
February 7, 2019 Lupin receives FDA approval for Tadalafil Tablets USP, 20 mg
-
February 6, 2019 Lupin Quarter III, FY2019 – Results
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications